Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01656681 · ClinicalTrials.gov registry record · NA

Effect of a Novel Nutraceutical on Weight Loss and Weight Maintenance in Obese Subjects

A NA study of Obesity, sponsored by MetaProteomics.

Completed
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT01656681: Completed NA study of Obesity, sponsored by MetaProteomics.

NCT01656681 is a NA study of Obesity that has completed, run by MetaProteomics. The registered enrollment target is 130 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01656681, a NA study of Obesity, has completed, sponsored by MetaProteomics.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

The purpose of this 2-stage intervention study is to investigate the effect of a novel nutraceutical (containing tetrahydro iso-alpha acids derived from hops) on weight loss and weight loss maintenance in obese participants.

Conditions Studied

Obesity

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT THIAA

Study Locations (1)

Washington

  • Functional Medicine Research Center - Gig Harbor

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2011-05
Est. Completion 2012-12
Phase NA

Sponsor

MetaProteomics

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01656681

The ClinicalTrials.gov registry entry for NCT01656681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (84% lower). The listed sponsor is MetaProteomics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01656681 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT01656681 about?

NCT01656681 is a clinical study titled "Effect of a Novel Nutraceutical on Weight Loss and Weight Maintenance in Obese Subjects". The purpose of this 2-stage intervention study is to investigate the effect of a novel nutraceutical (containing tetrahydro iso-alpha acids derived from hops) on weight loss and weight loss maintenance in obese participants.

What is the current status of trial NCT01656681?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2011-05. Estimated completion is 2012-12.

What conditions does trial NCT01656681 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT01656681?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), THIAA (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01656681?

This trial is sponsored by MetaProteomics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01656681 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Washington

All trials with a study site in Washington

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.